Latest1 information on COVID-19
©2022 Stanford Medicine
Molecular Analysis of Thoracic Malignancies
Recruiting
I'm InterestedTrial ID: NCT01385722
Purpose
A research study to learn about the biologic features of cancer development, growth, and
spread. We are studying components of blood, tumor tissue, normal tissue, and other fluids,
such as urine, cerebrospinal fluid, abdominal or chest fluid in patients with cancer. Our
analyses of blood, tissue, and/or fluids may lead to improved diagnosis and treatment of
cancer by the identification of markers that predict clinical outcome, markers that predict
response to specific therapies, and the identification of targets for new therapies.
Official Title
Molecular Analysis of Thoracic Malignancies
Stanford Investigator(s)
Joel Neal, MD, PhD
Associate Professor of Medicine (Oncology)
Kavitha Ramchandran
Clinical Associate Professor, Medicine - Oncology
Seema Nagpal, MD
Clinical Associate Professor, Neurology & Neurological Sciences Clinical Associate Professor (By courtesy), Neurosurgery
Heather Wakelee
Professor of Medicine (Oncology)
Maximilian Diehn, MD, PhD
Jack, Lulu, and Sam Willson Professor and Professor of Radiation Oncology (Radiation Therapy)
Billy W Loo, Jr, MD PhD FASTRO FACR
Professor of Radiation Oncology (Radiation Therapy)
Eligibility
Inclusion Criteria:
1.Histologically proven diagnosis of non-small cell lung cancer, small cell lung cancer,
thymoma, thymic carcinoma, mesothelioma, or carcinoma of unknown primary consistent with
the presentation of a primary thoracic malignancy.
2.18 years of age or older.
3.Ability to understand and the willingness to sign a written informed consent document.
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Jordan Preiss
650-723-1002